Pulmonary Medicine - Global Cardiology Academy

1-16 of 33

Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
AudioAbstracts
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
Ryan Quigley
- Ryan Quigley
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Clinician's Roundtable
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Clinician's Roundtable
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Athlete-Focused CPET: Interpreting Physiology Beyond Standardized Testing
Athlete-Focused CPET: Interpreting Physiology Beyond Standardized Testing
Heart Matters
Athlete-Focused CPET: Interpreting Physiology Beyond Standardized Testing
Benjamin Levine, MD, FACC
- Benjamin Levine, MD, FACC
Bringing PAH Care Home with Wearables and Telemedicine
Bringing PAH Care Home with Wearables and Telemedicine
Clinician's Roundtable
Bringing PAH Care Home with Wearables and Telemedicine
Daniel Lachant, D.O.
- Daniel Lachant, D.O.
Examining Barriers to Digital Healthcare in PAH
Examining Barriers to Digital Healthcare in PAH
Clinician's Roundtable
Examining Barriers to Digital Healthcare in PAH
Daniel Lachant, D.O.
- Daniel Lachant, D.O.
Understanding CPET for Athletes: Protocols and Pitfalls
Understanding CPET for Athletes: Protocols and Pitfalls
Heart Matters
Understanding CPET for Athletes: Protocols and Pitfalls
Benjamin Levine, MD, FACC
- Benjamin Levine, MD, FACC
Leveraging Wearables for Pulmonary Arterial Hypertension Care
Leveraging Wearables for Pulmonary Arterial Hypertension Care
Clinician's Roundtable
Leveraging Wearables for Pulmonary Arterial Hypertension Care
Daniel Lachant, D.O.
- Daniel Lachant, D.O.
Fatty Acid Profiles May Be Linked to PAH Risk
Fatty Acid Profiles May Be Linked to PAH Risk
AudioAbstracts
Fatty Acid Profiles May Be Linked to PAH Risk
Ryan Quigley
- Ryan Quigley
Targeting Macrophages in Pulmonary Arterial Hypertension
Targeting Macrophages in Pulmonary Arterial Hypertension
Clinician's Roundtable
Targeting Macrophages in Pulmonary Arterial Hypertension
Reframing Palliative Care in PAH: Early Integration to Improve Outcomes
Reframing Palliative Care in PAH: Early Integration to Improve Outcomes
Clinician's Roundtable
Reframing Palliative Care in PAH: Early Integration to Improve Outcomes
Hidden HFpEF in Atrial Fibrillation: A Missed Diagnosis with Real Consequences
Hidden HFpEF in Atrial Fibrillation: A Missed Diagnosis with Real Consequences
Heart Matters
Hidden HFpEF in Atrial Fibrillation: A Missed Diagnosis with Real Consequences
Decoding COPD: Precision Medicine Approaches for Complex Patient Profiles
Decoding COPD: Precision Medicine Approaches for Complex Patient Profiles
Pulmonary Medicine
Decoding COPD: Precision Medicine Approaches for Complex Patient Profiles
Matthew Moll, MD, MPH
- Matthew Moll, MD, MPH
The Future of Precision Medicine in COPD Care: Biomarkers, AI, and Multimodal Data
The Future of Precision Medicine in COPD Care: Biomarkers, AI, and Multimodal Data
Pulmonary Medicine
The Future of Precision Medicine in COPD Care: Biomarkers, AI, and Multimodal Data
Matthew Moll, MD, MPH
- Matthew Moll, MD, MPH
ECG Markers as Predictors of Adverse Outcomes in COPD: Insights from the IMPACT Trial
ECG Markers as Predictors of Adverse Outcomes in COPD: Insights from the IMPACT Trial
Cardiology
ECG Markers as Predictors of Adverse Outcomes in COPD: Insights from the IMPACT Trial
Raymond Wade, MD
- Raymond Wade, MD
Bridging the Gap in COPD Care: A Primary Care and Pulmonary Partnership
Bridging the Gap in COPD Care: A Primary Care and Pulmonary Partnership
Pulmonary Medicine
Bridging the Gap in COPD Care: A Primary Care and Pulmonary Partnership
Megan Conroy, MD
- Megan Conroy, MD

Prev
1
2
3
Next

1/3